News
Merck disappoints by failing in phaseIII study of its drug which cures Alzheimer’s
The drug, verubecestat, was being tested in patients who showed only a glimmer of the symptoms that eventually rob them of memories and basic...
News
Oxford BioMedia could gain $100 million in sanofi invasion target
UK gene cell therapy designer Oxford BioMedica’s shares jumped as much as 11.2% to 12.30 pence this morning after announcing a $100 million collaboration...
News
Pharma pioneer Sanofi guards its Dengvaxia
You do not get severe dengue from the vaccine. Just because you were administered with the vaccine means you’ll get infected. That’s s a...
Industry Reports
Roche acquires a software company named Flatiron health
Swiss pharmaceutical giant Roche Group is buying Flatiron Health, an Alphabet-backed cancer-focused start-up founded by two former Google employees, according to sources familiar with...
News
Pfizer gets BREAKTHROUGH THERAPY designation from FDA for patients suffering with ATOPIC DERMATITIS
Pfizer Inc. (NYSE:PFE) today announced its once-daily oral Janus kinase 1 (JAK1) inhibitor PF-04965842 received Breakthrough Therapy designation from the U.S. Food and Drug...
News
Pfizer invests $147M investment in portage
The world's largest pharmaceutical manufacturing plant is now 98,500 square feet larger.And that expansion -- the most visible part of an ongoing $147 million...
News
Apple, Intel, Merck, Pfizer, GE are Pimco’s Big buys
Pimco is the largest bond investor, but it also manages quite a bit in equities. According to S&P Capital IQ, Pimco now oversees $5.1...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read